DK169586A - Minactivin - Google Patents

Minactivin Download PDF

Info

Publication number
DK169586A
DK169586A DK169586A DK169586A DK169586A DK 169586 A DK169586 A DK 169586A DK 169586 A DK169586 A DK 169586A DK 169586 A DK169586 A DK 169586A DK 169586 A DK169586 A DK 169586A
Authority
DK
Denmark
Prior art keywords
minactivin
Prior art date
Application number
DK169586A
Other languages
English (en)
Other versions
DK169586D0 (da
Inventor
Ross Wentworth Stephens
Jeffrey Philip Golder
Neil Howard Goss
Toni Marie Antalis
Original Assignee
Biotech Australia Pty Ltd
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd, Univ Australian filed Critical Biotech Australia Pty Ltd
Publication of DK169586D0 publication Critical patent/DK169586D0/da
Publication of DK169586A publication Critical patent/DK169586A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • C07K14/8132Plasminogen activator inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811Serine protease (E.C. 3.4.21) inhibitors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121Serpins
    • G01N2333/8132Plasminogen activator inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DK169586A 1984-08-13 1986-04-14 Minactivin DK169586A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPG653184 1984-08-13
PCT/AU1985/000191 WO1986001212A1 (en) 1984-08-13 1985-08-13 Minactivin

Publications (2)

Publication Number Publication Date
DK169586D0 DK169586D0 (da) 1986-04-14
DK169586A true DK169586A (da) 1986-06-06

Family

ID=3770719

Family Applications (1)

Application Number Title Priority Date Filing Date
DK169586A DK169586A (da) 1984-08-13 1986-04-14 Minactivin

Country Status (8)

Country Link
EP (1) EP0192671B1 (da)
JP (3) JPH0655152B2 (da)
CN (1) CN1019355B (da)
CA (1) CA1341407C (da)
DE (1) DE3587711T2 (da)
DK (1) DK169586A (da)
NZ (1) NZ213091A (da)
WO (1) WO1986001212A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422090A (en) * 1984-08-13 1995-06-06 Biotechnology Australia, Pty., Ltd. Human PAI-2
IL81879A (en) * 1986-03-13 1994-07-31 Biotech Australia Pty Ltd Purification of minactivin for homogeneity, production of minactivin as recombinant techniques, and uses of homogeneous or recombinant minactivin
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation
DK0458937T3 (da) * 1989-12-20 1998-02-23 Biotech Australia Pty Ltd Varianter af PAI-2
DE69832184D1 (de) * 1997-07-31 2005-12-08 Hoffmann La Roche O-substituierte hydroxycumaranonderivate mit antitumoraler und antimetastatischer wirkung

Also Published As

Publication number Publication date
NZ213091A (en) 1991-05-28
DE3587711T2 (de) 1994-04-28
JPH07133297A (ja) 1995-05-23
JPS61502961A (ja) 1986-12-18
AU4679585A (en) 1986-03-07
CN85107267A (zh) 1987-04-08
CN1019355B (zh) 1992-12-09
EP0192671A1 (en) 1986-09-03
DE3587711D1 (de) 1994-02-10
DK169586D0 (da) 1986-04-14
WO1986001212A1 (en) 1986-02-27
EP0192671B1 (en) 1993-12-29
EP0192671A4 (en) 1987-01-22
JPH0739387A (ja) 1995-02-10
AU596949B2 (en) 1990-05-24
JPH0655152B2 (ja) 1994-07-27
CA1341407C (en) 2002-12-10

Similar Documents

Publication Publication Date Title
AT380762B (de) Hoergeraet
AT379929B (de) Hoergeraet
NO850495L (no) Roerskjoet
ATA98284A (de) Schalplatte
ATA135485A (de) Maishaecksler
AT386724B (de) Haecksler
ATA237384A (de) Maehwerk
DK169586D0 (da) Minactivin
ATE36715T1 (de) 7-d-mandelamido-3-(1-sulfomethyltetrazol-5us840229
ATA45484A (de) Kimme
AT389296B (de) Elektrokoagulator
DD257749A3 (de) Parallelschieber
FI840484A0 (fi) Baerande akter till motorbaot
BR8404272A (pt) Extensao
RO90516A2 (ro) Racord rapid
RO88255A2 (ro) Racord rapid
SE8401359D0 (sv) Uppslitsa stuprennor-stupror
BR8401157A (pt) Auto-balsa
BR6401828U (pt) Panquequeira
BR6401608U (pt) Omeleteira
BR6401138U (pt) Kriptograma
BR8404566A (pt) Paramortecedor
BR6400697U (pt) Sobre-encosto/sobre-assento
BR6400601U (pt) Fotocheque
BR8404385A (pt) Regua nautica

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired